Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Biocon Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

PFIZER vs BIOCON LTD - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More


Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More


Current Valuations

P/E (TTM) x 31.3 41.0 76.3% View Chart
P/BV x 4.9 7.1 69.5% View Chart
Dividend Yield % 0.7 0.2 423.9%  


5-Yr Chart
Click to enlarge
High Rs2,3651,188 199.1%   
Low Rs1,625305 532.8%   
Sales per share (Unadj.) Rs430.368.7 626.1%  
Earnings per share (Unadj.) Rs78.77.6 1,042.2%  
Cash flow per share (Unadj.) Rs93.214.0 667.0%  
Dividends per share (Unadj.) Rs20.001.00 2,000.0%  
Dividend yield (eoy) %1.00.1 748.4%  
Book value per share (Unadj.) Rs586.586.3 679.2%  
Shares outstanding (eoy) m45.75600.00 7.6%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x4.610.9 42.7%   
Avg P/E ratio x25.398.9 25.6%  
P/CF ratio (eoy) x21.453.4 40.1%  
Price / Book Value ratio x3.48.6 39.3%  
Dividend payout %25.413.2 191.9%   
Avg Mkt Cap Rs m91,271447,900 20.4%   
No. of employees `0002.66.1 42.8%   
Total wages/salary Rs m3,1439,311 33.8%   
Avg. sales/employee Rs Th7,484.86,705.8 111.6%   
Avg. wages/employee Rs Th1,195.01,514.2 78.9%   
Avg. net profit/employee Rs Th1,369.1736.9 185.8%   
Net Sales Rs m19,68541,234 47.7%  
Other income Rs m1,1432,062 55.4%   
Total revenues Rs m20,82843,296 48.1%   
Gross profit Rs m5,0038,291 60.3%  
Depreciation Rs m6633,851 17.2%   
Interest Rs m4615 0.7%   
Profit before tax Rs m5,4795,887 93.1%   
Minority Interest Rs m0213 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,8781,569 119.7%   
Profit after tax Rs m3,6014,531 79.5%  
Gross profit margin %25.420.1 126.4%  
Effective tax rate %34.326.7 128.6%   
Net profit margin %18.311.0 166.5%  
Current assets Rs m24,16741,486 58.3%   
Current liabilities Rs m9,54421,413 44.6%   
Net working cap to sales %74.348.7 152.6%  
Current ratio x2.51.9 130.7%  
Inventory Days Days5564 86.1%  
Debtors Days Days2994 30.5%  
Net fixed assets Rs m9,51450,661 18.8%   
Share capital Rs m4583,000 15.3%   
"Free" reserves Rs m26,37548,808 54.0%   
Net worth Rs m26,83251,808 51.8%   
Long term debt Rs m2517,898 0.1%   
Total assets Rs m36,90099,897 36.9%  
Interest coverage x1,305.510.6 12,348.7%   
Debt to equity ratio x00.3 0.3%  
Sales to assets ratio x0.50.4 129.2%   
Return on assets %9.85.2 189.7%  
Return on equity %13.48.7 153.4%  
Return on capital %20.49.6 211.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2212,058 0.2%   
Fx outflow Rs m1,4897,348 20.3%   
Net fx Rs m-1,4664,710 -31.1%   
From Operations Rs m3,3186,621 50.1%  
From Investments Rs m-2,383-6,840 34.8%  
From Financial Activity Rs m-1,104-2,397 46.0%  
Net Cashflow Rs m-169-2,612 6.5%  

Share Holding

Indian Promoters % 0.0 40.4 -  
Foreign collaborators % 63.9 20.6 310.2%  
Indian inst/Mut Fund % 7.5 8.4 89.3%  
FIIs % 4.9 10.7 45.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 19.9 119.1%  
Shareholders   85,207 109,995 77.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster


Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Today's Market

Sensex Trades Higher; Vedanta & Tata Steel Top Gainers(12:30 pm)

Share markets in India are presently trading on a positive note. Barring FMCG sector, all sectoral indices are trading on a positive note with stocks in the metal sector.

Related Views on News

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, PFIZER has posted a net profit of Rs 958 m (down 13.8% YoY). Sales on the other hand came in at Rs 5 bn (down 9.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

More Views on News

Most Popular

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

How We Pick the Most Profitable Stocks from the Portfolios of Super Investors(The 5 Minute Wrapup)

Feb 8, 2019

This is the trick to following super investors and not losing money.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.


Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms


Feb 20, 2019 12:51 PM